SciELO - Scientific Electronic Library Online

 
vol.34 número1A influência da quimioterapia no estado nutricional e na fadiga oncológica em pacientes oncológicos: estudo transversalAnálise espaço-temporal da incidência, mortalidade e letalidade da COVID-19 no Estado do Rio Grande do Norte, no período de 2020 a 2022, no Nordeste do Brasil índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

artigo

Indicadores

Compartilhar


Journal of Human Growth and Development

versão impressa ISSN 0104-1282versão On-line ISSN 2175-3598

J. Hum. Growth Dev. vol.34 no.1 Santo André jan. 2024  Epub 20-Jan-2025

https://doi.org/10.36311/jhgd.v34.15776 

ORIGINAL ARTICLE

Epidemiological evolution of COVID-19: a three-year perspective on coping with the Pandemic in the States of Rio Grande do Sul and Paraná, Southern region of Brazil

Daniel Alvarez Estradaa  b 

Silvana de Azevedo Britoa  b 

Marcelo Ferraz de Camposc 

Alzira Alves de Siqueira Carvalhoa 

aPrograma de Pós-Graduação em Ciências da Saúde, Centro Universitário FMABC - Santo André, São Paulo, Brasil;

bLaboratório de Delineamento de Estudo e Escrita Científica, Centro Universitário FMABC - Santo André, São Paulo, Brasil;

cDepartamento de Neurocirurgia, Completo Hospitalar Heliopolis – São Paulo, São Paulo, Brasil.


Authors summary

Why was this study done?

This study was undertaken to analyze the panorama of the COVID-19 pandemic in the states of Paraná and Rio Grande do Sul, focusing on a detailed understanding of epidemiological indicators such as mortality, fatality rate, and incidence. Throughout the investigation, researchers highlighted significant differences between these two states, consistently emphasizing that Paraná consistently showed higher values in incidence, mortality, and fatality rate compared to Rio Grande do Sul.

What did the researchers do and find?

The researchers explored the impact of public management and preventive measures on the evolution of the pandemic. A relevant finding was the initially high fatality rate in Paraná, possibly associated with delays in implementing preventive protocols and a lack of population adherence to non-pharmacological methods for preventing COVID-19. These conclusions emphasize the importance of effective pandemic management, early implementation of preventive measures, and population engagement as critical factors that influenced the epidemiological outcomes in the analyzed states.

What do these findings mean?

The discoveries from this study hold significant implications, emphasizing the need to consider socioeconomic factors, social inequalities, and characteristics of urban infrastructure in disease spread. Additionally, they underscore the importance of evidence-based prevention and control policies, continuous monitoring, and the implementation of intervention strategies to mitigate the impacts of COVID-19. This is a call to maintain attention on the continuity of preventive measures, even in the face of vaccination progress, aiming to ensure a comprehensive approach to public health protection.

Key words: COVID-19; incidence; case fatality; mortality; trend

Abstract

Introduction

The novel Coronavirus disease (COVID-19) is caused by SARS-CoV-2 and represents the agent responsible for a respiratory and metabolic disease with a high fatality rate, remaining a public health problem to this day. There has been an exacerbation of social inequalities experienced in Brazil and worldwide. Notably, the absence of a consolidated and universal healthcare system has contributed to the increased inequalities and survival opportunities for those affected by SARS-CoV-2 infection and manifestation of COVID-19. The southern region has become the second region with the highest number of cases in Brazil.

Objective

To avaluate the epidemiological outcomes of incidence, lethality, and mortality among the states of Rio Grande do Sul and Paraná in the southern region of Brazil.

Methods

An ecological time-series study was conducted using official secondary data on COVID-19 cases and deaths publicly disclosed by the health departments of the states of Rio Grande do Sul and Paraná. Time series were constructed applying the Prais-Winsten regression model. Statistical analyses were performed using STATA 14.0 software.

Results

It was observed that for the state of Rio Grande do Sul, the trends regarding incidence were increasing in 2020 and decreasing in 2021 (p<0.05). Regarding mortality, it increased in 2020 and decreased in 2021 and 2022 (p<0.05). When assessing lethality, a decreasing trend was observed for the entire period (p<0.05). In relation to Paraná, incidence increased in 2020 and over the entire period, while it decreased in 2021 and 2022 (p<0.05). Mortality was stationary in 2020 and decreased in 2021 and 2022 (p<0.05).

Conclusion

The COVID-19 pandemic is a serious public health problem in the states of Paraná and Rio Grande do Sul. Paraná presented a more severe epidemiological outcome compared to Rio Grande do Sul.

Key words: COVID-19; incidence; case fatality; mortality; trend

Highlights

This study was based on a comprehensive and comparative approach to the evolution of the COVID-19 pandemic in the states of Paraná and Rio Grande do Sul. Researchers emphasize the influence of factors such as public management, preventive measures, and socioeconomic characteristics on the disease’s dynamics. Furthermore, the detailed temporal analysis, considering specific indicators such as lethality and incidence, provides valuable insights. The inclusion of elements like social inequalities and urban infrastructure reinforces the multifaceted understanding of virus spread. This integrated approach contributes to adapting regional public policies, highlighting the ongoing need for personalized strategies and vigilant monitoring amid the challenges of the pandemic.

Key words: COVID-19; incidence; case fatality; mortality; trend

Resumo

Introdução

a doença do novo Coronavírus (COVID-19) é causada pelo SARS-CoV-2 e representa o agente causador de uma doença respiratória e metabólica com alto índice de fatalidade e continua sendo um problema de saúde pública nos dias atuais. Houve o agravamento das desigualdades sociais vividas no Brasil e no mundo. Notadamente, a ausência de um sistema de saúde consolidado e universal contribuiu para o aumento das desigualdades e oportunidades de sobrevida daqueles acometidos com a infecção do SARs-CoV2 e manifestação da COVID-19. A região sul se tornou a segunda região com maior número de casos no Brasil.

Objetivo

avaliar os desfechos epidemiológicos da incidência, letalidade e mortalidade entre os estados do Rio Grande do Sul e Paraná, na região Sul brasileira.

Método

foi realizado um estudo ecológico de séries temporais utilizando dados secundários oficiais de divulgação pública governa4mental casos e mortes por COVID-19 do painel da Secretaria Estadual de Saúde dos estados de Rio Grande do Sul e Paraná. As séries temporais foram construídas aplicando o modelo de regressão de Prais-Winsten. As análises estatísticas foram realizadas com o uso do software STATA 14.0.

Resultados

Verificou-se que para o estado do Rio Grande do Sul as tendências em relação à incidência foram crescentes no ano de 2020 e decrescente no ano de 2021 (p<0,05). Já em relação a mortalidade foi crescente em 2020 e decrescente em 2021 e 2022 (p<0,05). Quando verificou-se a letalidade, foi observado que a tendência para o período inteiro foi decrescente (p<0,05). Em relação ao Paraná a incidência foi crescente no ano de 2020 e no período inteiro enquanto foi decrescente no ano de 2021 e 2022 (p<0,05). Já a mortalidade foi estacionaria no ano de 2020 e decrescente no ano de 2021 e 2022 (p<0,05).

Conclusão

A pandemia da COVID-19 é um grave problema de saúde pública nos estados do paraná e Rio Grande do Sul. O estado do Paraná apresentou um quadro de maior gravidade nos desfechos epidemiológico, em comparação ao estado do Rio Grande do Sul.

Palavras-Chave: COVID-19; incidência; letalidade; mortalidade; tendência

INTRODUCTION

The COVID-19 pandemic is far from over. The SARS-CoV-2 virus and its variants continue to circulate. Three years into the global experience of the COVID-19 pandemic, its effects persist on global public health, the economy, and international relations among people and countries. A new work and commercial relationship is being experienced. There’s clear scientific advancement, particularly in the field of drug development, with COVID-19 vaccines being tested in large, randomized controlled trials involving individuals across a wide age range, both sexes, different ethnicities, and those with known medical conditions. The world has changed!

The World Health Organization (WHO) was alerted in mid-December 2019 about several cases of pneumonia concentrated in the city of Wuhan, Hubei province, People’s Republic of China. It was a new type of coronavirus not yet identified in humans. On January 7, 2020, Chinese authorities confirmed a new type of coronavirus, named SARS-CoV-2, responsible for causing the disease COVID-191,2.

Coronaviruses (CoV) are a broad family of viruses that can cause a variety of conditions, from the common cold to more severe illnesses such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV)2.

The novel coronavirus (nCoV) is a new strain of coronavirus that had not previously been identified in humans. Known as 2019-nCoV or COVID-19, it was only detected after reports of an outbreak in Wuhan, China, in December 20192.

The pathogen causing this outbreak was identified as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As COVID-19 cases rapidly spread worldwide, the World Health Organization (WHO) declared it a pandemic on March 11, 20203.

The disease caused by the novel Coronavirus (COVID-19) is brought about by SARS-CoV-2 and is characterized as a respiratory and metabolic illness with a high fatality rate, continuing to pose a public health problem today1,4. Since its emergence in late 2019, the initial waves of the COVID-19 pandemic challenged the classical model of tackling communicable diseases due to the absence of strictly pharmacological actions in the public health portfolio.

Due to its high potential for transmission and global distribution, on January 30, 2020, the WHO declared the ‘Novel Coronavirus’ as a Public Health Emergency of International Concern (PHEIC). In Brazil, the epidemic was declared a Public Health Emergency of National Importance (PHENI) on February 3, 20205.

The first case of COVID-19 in Brazil was recorded on February 26, 2020, in the city of São Paulo. Subsequently, the disease spread rapidly, affecting all regions of Brazil regardless of their political, socioeconomic, and healthcare conditions6.

In early 2020, only non-pharmacological measures such as social distancing, the use of face masks, and hand hygiene were reported. This was because Epidemiology presented solid evidence that social isolation would be the best strategy, allowing people to become infected at a slower pace, enabling the healthcare system to handle the full extent of severe cases of COVID-19 development7.

These measures resulted in some societal damage, especially affecting vulnerable populations: the poor, women, and workers. Consequently, there was an exacerbation of social inequalities experienced in Brazil and worldwide. Notably, the absence of a consolidated and universal healthcare system contributed to increased inequalities and survival opportunities for those affected by SARS-CoV-2 infection and manifestation of COVID-198. Globally, as of April 12, 2023, there have been 762,791,152 confirmed cases of COVID-19, including 6,897,025 deaths reported by the WHO. The highest number of confirmed cases was concentrated in the European Continent with 275,110,560 confirmed cases, followed by the Western Pacific with 202,153,158 and the Americas with 191,814,9664.

According to the World Health Organization (WHO), as of July 9, 2023, there have been 768,237,788 confirmed cases of COVID-19, including 6,951,677 deaths reported to the WHO, with Brazil ranking sixth in the world in terms of COVID-19 cases, with 37,693,506 confirmed cases and 704,320 deaths4,5.

It is known that Brazil has significant social inequalities that can influence the spread of COVID-19. There’s a higher risk of illness in areas with high incidence rates and inequalities in income and wealth, as well as greater social vulnerability, poverty, and social inequalities in health9. Social inequality and poor housing conditions in Brazil contribute to the spread of COVID-19. Precarious housing made it difficult for individuals and families to practice social distancing, limited access to basic hygiene and personal protective products, and created barriers to accessing healthcare services for vulnerable populations10.

The Southeast was the region with the highest number of cases, totaling 14,855,889, followed by the South region with 7,928,381, the Northeast with 7,736,349, the Midwest with 4,305,185, and finally, the North region with 2,863,450. The highest number of deaths occurred in the Southeast region11.

The southern region of Brazil became the second region with the highest number of cases in the country. Rio Grande do Sul totaled 3,016,376 cases and 42,065 deaths as of April 19, 2023. The highest number of deaths was concentrated in the 70 to 79-year-old male group, of which 2,961,962 patients (98%) recovered12.

The state of Paraná has a population of 11,443,208 people, with a population density of 57.42 inhabitants per square kilometer. Until April 17, 2023, in Paraná, 2,919,573 cases and 45,951 deaths due to COVID-19 were confirmed, totaling 2,235 cases and 68 deaths in the last 7 days, and 2,863,447 (98.08%) of patients have recovered. The average age of deaths was 65 years, more prevalent in females (57%), while the average age of cases was 39 years, more prevalent in males13.

Paraná is one of Brazil’s most developed states, ranking 7th in the Human Development Index (0.749), the highest in the country14. Its culture has been influenced by migration processes of both Brazilians and foreigners with strong European origins. The state’s economy relies on agricultural and industrial activities, along with a robust tourism sector14.

In comparison, Rio Grande do Sul represents approximately 5.4% of Brazil’s population and has become the 6th most populous state in Brazil. It boasts the fourth-largest GDP and the sixth-highest HDI (0.780) in the country. It is a state with a higher number of elderly individuals and the second-highest life expectancy. Its population density is 38.62 inhabitants per square kilometer, with a population of 10,880,506 people14.

Regarding the economy, Rio Grande do Sul holds a strong agricultural influence, producing around 90% of grapes and wines and 70% of rice. Additionally, it’s the third-largest producer of soybeans and corn in the country and ranks third in pork production. Another economic sphere is its high degree of industrialization, with a focus on petrochemical, tobacco, footwear, construction, food, automotive, and naval industries within its industrial park14.

As such, due to its vast continental size, Brazil presents a complex epidemiological scenario with climatic, vegetative, cultural, and socioeconomic divergences8. Notably, the spread of COVID-19 has shown heterogeneous dynamics influenced by socioeconomic determinants and variations in available healthcare services3.

The fundamentals of syndemic theory are real and allow us to understand disease distribution, given that political-economic factors experienced over generations have resulted in social, cultural, and power inequalities. Consequently, these inequalities alter the distribution of health risks and resources, resulting in social and spatial clustering of epidemic diseases15.

Thus, considering the impact of the COVID-19 pandemic on the socioeconomic sphere and the Brazilian healthcare system, given the regional heterogeneity and high number of cases and deaths in the states of Rio Grande do Sul and Paraná, this study aims to evaluate the epidemiological outcomes of incidence, fatality, and mortality between the states of Rio Grande do Sul and Paraná in the southern region of Brazil.

METHODS

Study design and location

An ecological time-series study was conducted16. Time-series analyses are necessary for making valid inferences from data, accounting for correlations among repeated observations over time17.

Official secondary data on COVID-19 cases and deaths from the panels of the State Health Secretariat of Rio Grande do Sul (https://ti.saude.rs.gov.br/covid19/) and Paraná (https://www.saude.pr.gov.br/Pagina/Coronavirus-COVID-19) were used for analysis. The sociodemographic characteristics of Rio Grande do Sul and Paraná are presented in table 1.

Table 1 : Sociodemographic Characteristics of Rio Grande do Sul and Paraná, Southern Region of Brazil 

Sociodemographic characteristic Rio Grande do Sul Paraná
Region* South South
Number of municipalities* 497 284
State Capital* Porto Alegre Curitiba
Territorial extension* (2022) 281748 km2 199298981 km2
Estimated population (2021) 11466630 people 11597484 people
Population density* (last census, 2010) 39.79 hab/km2 40 hab/km2
Urban household situation (2010)* 9100291 people 8912692 people
Rural household situation (2010)* 1593638 people 1531834 people
Monthly household per capita income* R$ 2087 R$ 1846
Human Development Index (HDI) (last census, 2010)* 0.746 0.749
Number of Basic Health Units of the Unified Health System (SUS) (2009)* 3868 establishments 4091 establishments
SUS outpatient* 3006 establishments 3307 establishments
SUS dialysis* 81 establishments 69 establishments
SUS emergency* 327 establishments 446 establishments
SUS hospitalization* 324 establishments 411 establishments
SUS ICU* 71 establishments 76 establishments
Number of beds for hospitalization in healthcare facilities (2009)* 31055 beds 26793 beds
Public* 4400 beds 6512 beds
Private* 26615 beds 20281 beds

Source: IBGE.

Sampling and Eligibility Criteria

All COVID-19 cases and deaths reported from March 2020 to December 2022 in the states of Rio Grande do Sul and Paraná were included. Occurrences were confirmed through laboratory, clinical, and clinical-epidemiological diagnoses. COVID-19 was categorized according to the International Classification of Diseases, 10th edition (ICD-10) as “U07.1 COVID-19, virus identified” or “U07.2 COVID-19, virus unidentified”.

Deaths and cases were classified by the date of symptom onset; additionally, cases without information on notification or death date were excluded from the study. A second author verified the extracted data, and a third investigator conducted a final check in case of discrepancies. Finally, the information was recorded in an Excel spreadsheet (Microsoft Corporation, Redmond, WA, USA).

Statistical analysis

The number of COVID-19 cases and deaths were described by absolute frequency (n) and relative frequency (%). For each state, the incidence rate (number of cases per 100,000 inhabitants), mortality rate (number of deaths per 100,000 inhabitants), and fatality rate (%) were calculated as described below:

incidence = number of cases number of inhabtants ×100.000
mortality = number of deaths number of inhabtants ×100.000
letality = number of deaths number of cases ×100

For the population count, the Population Projection of each federative unit was considered. For the state of Rio Grande do Sul, the estimated population for the year 2020 (8,628,901 inhabitants), 2021 (8,710,364 inhabitants), and 2022 (8,789,130 inhabitants) was used. Meanwhile, for the state of Paraná, the estimated population was (11,516,840 inhabitants) for the year 2020, (11,597,484 inhabitants) for 2021, and (11,675,661 inhabitants) for 202214.

To analyze the trend, the Antunes and Cardoso protocol (2015)18 was used. Time series were constructed applying the Prais-Winsten regression model. It allowed for first-order autocorrelation to analyze the values of the time series and facilitate the assessment and classification of the incidence, mortality, and fatality into increasing, decreasing, or stable trends. Trends were classified as stable when the p-value was not significant (p > 0.05).

The probability (p) values and daily percent change (DPC), considering a significance level of 95%, were calculated using the equations below (1-2-3), where β represents the angular coefficient of the linear regression, the indices ul denote the upper limit, and ll is the lower limit of the confidence level.

VPD =(10β1)×100%
(IC95%)μl=(10β_max1)×100%
(IC95%)ll=(10β_min1)×100%

To compare proportions, the two-tailed z-test was used, considering differences significant when the p-value was < 0.05.

Statistical analyses were performed using STATA 14.0 software (College Station, TX, USA, 2013).

Ethical aspects

The data obtained from information systems maintained by the Ministry of Health are reliable, allowing their use as a feasible tool for analyzing COVID-19 epidemiological indicators. Since these are public data widely accessible, there is no need to seek approval from the Research Ethics Committee (CEP) for conducting this study.

RESULTS

Data extracted from the Coronavirus Panel database, spanning from 2020 to 2022, indicate that in the state of Rio Grande do Sul, 2,927,909 cases and 41,594 confirmed deaths (table 2) due to COVID-19 were reported, whereas in the state of Paraná, there were 2,888,258 cases and 45,815 deaths recorded (table 3).

Table 2 : Monthly distribution of confirmed COVID-19 cases and deaths in the state of Rio Grande do Sul, Brazil, from January 2020 to December 2022 

Year Month Confirmed cases Confirmed deaths
AF (n) RF (%) AF (n) RF (%)
2020 January 0 0 0 0
February 33 <0.01 0 0
March 1264 <0,01 4 <0.01
April 3607 0.12 60 0.14
May 10 175 0.34 182 0.43
June 25 581 0.87 440 1.05
July 57 060 1.94 1391 3.34
August 62 303 2.12 1606 3.86
September 48 290 1.64 1282 3.08
October 57 298 1.95 1000 2.40
November 121 909 4.16 1167 2.80
December 123 048 4.20 2111 5.07
2021 January 93 303 3.18 1776 4.26
February 189 941 6.48 2048 4.92
March 200 621 6.85 8445 20.30
April 96 858 3.30 4534 10.90
May 136 372 4.65 2964 7.12
June 104 827 3.58 2895 6.96
July 46 802 1.59 1697 4.07
August 31 093 1.06 796 1.91
September 26 665 0.91 616 1.48
October 31 607 1.07 664 1.59
November 18 519 0.63 595 1.43
December 19 411 0.66 257 0.61
2022 January 559 912 19.12 678 1.63
February 237 036 8.09 1431 3.44
March 52 772 1.80 606 1.45
April 36 897 1.26 196 0.47
May 115 364 3.94 293 0.70
June 94 756 3.23 482 1.15
July 87 758 2.99 425 1.02
August 47 428 1.61 356 0.85
September 9543 0.32 180 0.43
October 3776 0.12 59 0.14
November 39 493 1.34 72 0.17
December 136 587 4.66 286 0.68
Total 2 927 909 100.00 41 594 100.00

Source: Information extracted from the Coronavirus Panel on January 12, 2023, available at: < https://covid.saude.gov.br/>. AF: Absolute Frequency (n); RF: Relative Frequency (%)

Table 3 : Monthly distribution of confirmed COVID-19 cases and deaths in the state of Paraná, Brazil, from January 2020 to December 2022 

Year Month Confirmed cases Confirmed deaths
AF (n) RF (%) AF (n) RF (%)
2020 January 0 0 0 0
February 0 0 0 0
March 285 <0.01 6 0.01
April 1747 0.06 110 0.24
May 4647 0.16 125 0.27
June 24 357 0.84 625 1.36
July 57 817 2.00 1434 3.12
August 58 679 2.03 1570 3.42
September 49 528 1.71 1243 2.71
October 35 626 1.23 826 1.80
November 85 980 2.97 1048 2.28
December 125 809 4.35 2325 5.07
2021 January 119 206 4.12 1990 4.34
February 107 867 3.73 2044 4.46
March 173 553 6.00 6517 14.22
April 103 382 3.57 4516 9.85
May 196 949 6.81 4928 10.75
June 166 103 5.75 5443 11.88
July 72 616 2.51 2625 5.72
August 70 515 2.44 1592 3.47
September 60 445 2.09 1358 2.96
October 30 680 1.06 835 1.82
November 14 060 0.48 402 0.87
December 10 256 0.35 148 0.32
2022 January 477 423 16.52 647 1.41
February 318 867 11.04 1354 2.95
March 56 391 1.95 482 1.05
April 28 615 0.99 122 0.26
May 109 466 3.79 229 0.49
June 90 606 3.13 360 0.78
July 57 639 1.99 273 0.59
August 33 202 1.14 19–2 0.41
September 8156 0.29 87 0.18
October 4187 0.14 35 0.07
November 40 434 1.39 72 0.15
December 92 805 3.21 252 0.55
Total 2 888 258 100.00 45 815 100.00

Source: Information extracted from the Coronavirus Panel on January 12, 2023, available at: <https://covid.saude.gov.br/>.AF: Absolute Frequency (n); RF: Relative Frequency (%)

Tables 2 and 3 display the absolute and relative frequencies per month of cases and deaths during the studied period for the analyzed states.

In Rio Grande do Sul, the first confirmed case of COVID-19 was registered in February 2020. In that month, the cases accounted for 0.001% of the total cases over the three years of analysis. Regarding deaths, the first record occurred in the month following the onset of the first case, equivalent to 0.009% of the total deaths in the period analyzed.

In the initial year, the total confirmed cases and deaths due to COVID-19 were 510,568 and 9,243, respectively. During this year, the months with the highest cumulative number of confirmed cases were August (2.12%), November (4.16%), and December (4.20%). Concerning deaths, they were July (3.33%), August (3.86%), and December (5.07%) in the year 2020.

In 2021, the total number of cases was 996,019, while the number of deaths was 27,287. There was a notable increase in cases during the months of February (6.48%), March (6.85%), and May (4.65%), and for deaths during March (20.30%), April (10.90%), and May (7.12%) in the same period.

In the final year of analysis, in 2022, the total number of confirmed cases and deaths due to COVID-19 was 1,421,322 and 5,064, respectively. The months of January (19.12%), February (8.09%), and December (4.66%) stood out for cases, while January (1.63%), February (3.44%), and March (1.45%) were notable for deaths.

In Paraná, the first cases were initially recorded in March 2020, with a total of 285 cases (0.009% of the total cases) and 6 deaths (0.01% of the total deaths). In this state, in 2020, the total confirmed cases and deaths due to COVID-19 were 444,475 and 9,312, respectively.

The months with the highest number of registered cases were August (2.03%), November (2.97%), and December (4.35%), while the months with the highest numbers of confirmed COVID-19 deaths were July (3.12%), August (3.42%), and December (5.07%).

In 2021, the total number of confirmed cases and deaths due to COVID-19 was 1,125,632 and 32,398, respectively. The months that stood out for cases and deaths were the same: March (6.00%), May (6.81%), and June (5.75%). Regarding deaths, throughout the period, the values were: 14.22%, 10.75%, and 11.88%, respectively.

Looking at the year 2022, the total number of confirmed cases and deaths due to COVID-19 was 1,318,151 and 4,105, respectively. Concerning cases, the months with the highest values were January (16.52%), February (11.04%), and May (3.79%). When considering deaths, emphasis is given to January (1.41%), February (2.95%), and March (1.05%).

Table 4 demonstrates the incidence, mortality, and lethality rates of COVID-19 in both states.

Table 4 : Monthly distribution of mortality, lethality, and incidence rates of COVID-19 in the states of Rio Grande do Sul and Paraná, Brazil, from January 2020 to December 2022 

YEAR MONTHS Rio Grande do Sul Paraná
Mortality (100.000 hab.) Case Fatality (100%) Incidence (100.000 hab.) Mortality (100.000 hab.) Case Fatality (100%) Incidence (100.000 hab.)
2020 January 0 0 0 0 0 0
February 0 0 0.28 0 0 0
March 0.03 0.31 11.07 0.05 2.10 2.46
April 0.52 1.66 31.59 0.95 6.29 15.14
May 1.59 1.78 89.12 1.08 2.68 40.27
June 3.85 1.72 224.06 5.41 2.56 211.09
July 12.18 2.43 499.78 12.42 2.48 501.07
August 14.06 2.57 545.70 13.60 2.67 508.75
September 11.22 2.65 422.96 10.77 2.50 429.24
October 8.75 1.74 501.87 7.15 2.31 308.75
November 10.22 0.95 1067.79 9.08 1.21 745.15
December 18.49 1.71 1077.77 20.14 1.84 1090.33
TOTAL 80.95 1.81 4472.03 80.70 2.095 3852.09
2021 January 15.52 1.90 815.38 17.14 1.66 1027.25
February 17.89 1.70 1659.92 17.61 1.89 92953
March 73.80 4.20 1753.25 56.15 375 1495.58
April 39.62 4.68 846.45 38.91 4.36 890.88
May 25.90 2.17 1191.77 42.46 2.50 1697.19
June 25.29 2.76 916.09 46.90 3.27 1431.38
July 14.83 3.62 409.00 22.62 3.61 625.76
August 6.95 2.56 271.72 13.71 2.25 607.65
September 5.38 2.31 233.02 11.70 2.24 520.88
October 5.80 2.10 276.21 7.19 2.72 264.38
November 5.19 3.21 161.84 3.46 2.85 121.16
December 2.24 1.32 169.63 1.27 1.44 88.38
TOTAL 238.46 2.73 8704.35 279.18 2.87 9700.08
2022 January 5.91 0.12 4883.36 5.54 0.13 4092.32
February 12.48 0.60 2067.34 11.60 0.42 2733.23
March 5.28 1.14 460.25 4.13 0.85 483.36
April 1.70 0.53 321.80 1.04 0.42 245.27
May 2.55 0.25 1006.16 1.96 0.20 938.31
June 4.20 0.50 826.42 3.08 0.39 776.64
July 3.7 0.48 765.39 2.34 0.47 494.06
August 3.1 0.75 413.65 1.64 0.57 284.59
September 1.56 1.88 83.23 0.74 1.02 72.99
October 0.51 1.56 32.93 0.3 0.83 35.88
November 0.62 0.18 344.44 0.61 0.17 346.58
December 2.49 0.2 1191.26 2.16 0.27 795.49
TOTAL 44.16 0.35 12 396.29 35.18 0.31 11 298.79
TOTAL OVERALL 363.59 1.42 25 572.68 395.07 1.586 24 850.98

When observing tables 4 and 5, it can be noted that concerning the entire analyzed period, the incidence in the state of Rio Grande do Sul had higher rates in 2020, with emphasis on December (1077.77), and in 2022, notably in January (4883.36). The state of Paraná surpassed only in 2021, with a highlight in May (1697.19).

Regarding mortality, the years remain similar to the incidence (figure 3), with the state of Rio Grande do Sul obtaining higher annual rates in 2020 and 2022, particularly in December (18.59) and February (12.48), respectively. Paraná, in 2021, stood out in mortality during March (56.15) (figure 4).

Figure 3 : Graph of COVID-19 Fatality Rates in the States of Rio Grande do Sul and Paraná 

Table 6 : Prais-Winsten regression estimates and daily percentual variation (DPV) of COVID-19 mortality, fatality, and incidence rates in the state of Paraná, Brazil, from January 2020 to December 2022 

RATE/YEAR LINEAR REGRESSION
β P β (IC95%) β
Paraná
MORTALITY
2020 to 2022 -0.000557 0.119 -0.13 -0.29 ; 0.03 Stationary
2020 0.0060981 <0.001 1.41 1.04 ; 1.79 Increasing
2021 -0.0035531 <0.001 -0.81 -1.13 ; -0.50 Decreasing
2022 -0.0026543 <0.001 -0.61 -0.61 ; -0.84 Decreasing
CASE FATALITY
2020 to 2022 -0.0010223 <0.001 -0.24 -0.28 ; -0.19 Decreasing
2020 -0.0019057 <0.001 -0.44 -0.56 ; -0.31 Decreasing
2021 -0.0001992 0.351 -0.05 -0.14 ; 0.05 Stationary
2022 0.0008202 0.069 0.19 -0.01 ; 0.39 Stationary
INCIDENCE
2020 to 2022 0.0016438 0.001 0.38 0.16 ; 0.60 Increasing
2020 0.0118071 <0.001 2.76 1.94 ; 3.58 Increasing
2021 -0.0033085 <0.001 -0.76 -0.94 ; -0.58 Decreasing
2022 -0.0030327 <0.001 -0.70 -1.08 ; -0.31 Decreasing

β - Regression coefficient; P - p-value; DPD - Daily Percentual Variation; C95% - 95% confidence interval. *Statistical difference detected by the Prais-Winsten regression test, p<0.05.

In the aspect of fatality, it’s noticed that the percentages were higher in 2020 and 2021 in the state of Paraná, highlighting the months of April (6.29 and 4.36) in the studied years. Rio Grande do Sul showed the highest fatality percentage, emphasizing the month of September (1.88%), as shown in figure 5.

When examining the entire period, it becomes apparent that Paraná surpasses Rio Grande do Sul across all categories, with values of 25,850.98 for incidence, 395.07 for mortality, and 1.58% for lethality.

The trends of mortality rates, lethality, and incidence of COVID-19 in the states of Rio Grande do Sul and Paraná can be visualized in Table 5. For analyses considered statistically significant (p < 0.05), the daily percentage change (DPC) reveals the percentage of daily change, indicating an increase or decrease for the variables.

Table 5 : Prais-Winsten regression estimates and daily percent variation (DPV) of COVID-19 mortality, lethality, and incidence rates in the state of Rio Grande do Sul, Brazil, from January 2020 to December 2022 

RATE/YEAR LINEAR REGRESSION
β P VPD (IC95%) Tendency
Rio Grande do Sul
MORTALITY
2020 to 2022 0.0002123 0.63 0.05 -0.15 ; 0.25 Stationary
2020 -0.0071697 <0.001 1.66 1.31 ; 2.02 Increasing
2021 -0.0033074 <0.001 -0.76 -1.02 ; -0.50 Decreasing
2022 -0.0022546 <0.001 -0.61 -0.82 ; -0.40 Decreasing
CASE FATALITY
2020 to 2022 -0.0006079 <0.001 -0.14 -0.20 ; -0.08 Decreasing
2020 -0.0002408 0.305 -0.06 -0.16 ; 0.05 Stationary
2021 -0.0002838 0.473 -0.07 -0.24 ; 0.11 Stationary
2022 0.001096 0.107 0.25 -0.05 ; 0.56 Stationary
INCIDENCE
2020 to 2022 0.0009663 0.122 0.22 -0.06 ; 0.51 Stationary
2020 0.0073262 <0.001 1.70 1.31 ; 2.09 Increasing
2021 -0.0028033 <0.001 -0.64 -0.85 ; -0.43 Decreasing
2022 -0.0020065 0.295 -0.46 -1.32 ; 0.41 Stationary

β - Regression coefficient; P - p-value; DPD - Daily Percentual Variation; C95% - 95% confidence interval.*Statistical difference detected by the Prais-Winsten regression test, p<0.05.

For the state of Rio Grande do Sul, it can be observed that the incidence trend was increasing in 2020 and decreasing in 2021 (p<0.05). Regarding mortality, it showed an increasing trend in 2020 and decreasing trends in 2021 and 2022 (p<0.05). When examining fatality rates, it was noted that the trend for the entire period was decreasing (p<0.05).

In Paraná, the incidence was increasing in 2020 and for the entire period, while it decreased in 2021 and 2022 (p<0.05). Mortality increased in 2020 and decreased in 2021 and 2022 (p<0.05). It can be observed that fatality rates had a decreasing trend in 2020 and for the entire period analyzed, from 2020 to 2022 (p<0.05).

DISCUSSION

The analysis of COVID-19 data spanning from 2020 to 2022 in the Brazilian states of Rio Grande do Sul and Paraná reveals distinctive patterns in incidence, mortality, and fatality rates (tables 2 and 3). In Rio Grande do Sul, with 2,927,909 reported cases and 41,594 confirmed deaths, the temporal distribution indicates a surge in cases during specific months in 2020 and 2022, notably in December and January, while mortality rates experienced fluctuations throughout the study period. In contrast, Paraná, with 2,888,258 cases and 45,815 deaths, exhibited a consistent increase in incidence during 2020 and a subsequent decline in 2021 and 2022 (tables 4 and 5). The fatality rates in Paraná were notably higher in 2020 and 2021, particularly in April, compared to Rio Grande do Sul. Examining the monthly distribution of cases and deaths in both states highlights the dynamic nature of the pandemic (figure 1). In Rio Grande do Sul, the onset of COVID-19 cases in February 2020 marked a subsequent rise, peaking in August, November, and December of that year.

Figure 1 : COVID-19 Incidence Rates in the States of Rio Grande do Sul and Paraná 

Deaths mirrored this trend, reaching peaks in July, August, and December 2020. The year 2021 witnessed increased cases in February, March, and May, while deaths peaked in March, April, and May. In 2022, both cases and deaths were elevated in January, February, and December (figures 2 and 3). Paraná exhibited a similar trend, with notable peaks in cases and deaths during specific months in 2020, 2021, and 2022.

Figure 2 : COVID-19 Mortality Rates in the States of Paraná and Rio Grande do Sul 

Comparing the states, Rio Grande do Sul demonstrated higher incidence rates in 2020 and 2022, while Paraná surpassed only in 2021. Mortality rates followed a similar pattern, with Rio Grande do Sul leading in 2020 and 2022, while Paraná exhibited higher rates in 2021. Fatality percentages were notably higher in Paraná during 2020 and 2021, particularly in April, while Rio Grande do Sul exhibited the highest fatality percentage in September (figure 5). These findings underscore the importance of continuous monitoring and targeted interventions to address the evolving dynamics of the COVID-19 pandemic in these regions.

Understanding the behavior of the COVID-19 pandemic is associated with a detailed analysis of its mortality spread rate, fatality, incidence, and factors impacting these indicators. Therefore, it’s crucial for informing decisions and implementing measures to combat the virus’s spread. Throughout the study period, it was observed that Paraná surpasses Rio Grande do Sul in all categories, with higher values of incidence, mortality, and fatality.

At the beginning of the pandemic, from February to April 2020, the state of Paraná exhibited a significantly higher fatality rate compared to Rio Grande do Sul. This occurrence might be related to delayed disease prevention protocols and the population’s non-adherence to non-pharmacological methods for preventing COVID-19.

The first Law No. 20189 regarding preventive measures in Paraná was enacted on April 28, 202019. In comparison, in Rio Grande do Sul, preventive measures (Law No. 55.154) were instituted on April 1, 202012.

However, when providing a comparison between the epidemiological outcomes of the state of São Paulo, which enacted decree No. 55.154 on March 20, 202020, there seems to be a causal relationship regarding the political decision-making of implementing non-pharmacological policies and restrictions on people, which were implemented later in the state of Paraná at the onset of the pandemic.

This situation of analyzing the implementation date of public policies to control the COVID-19 pandemic, especially during the period of widespread circulation of the delta variant of Sars-CoV-221, indicates a delay in the population’s adherence to behavioral measures and in the reopening of commerce, influencing the control of SARS-CoV-2 dissemination in the state of Paraná.

The study by Klokner et al. (2021)22 analyzed the epidemiological profile and risk and protective variables for COVID-19 in the southern region of Brazil, composed of the states of Rio Grande do Sul, Paraná, and Santa Catarina. There was a trend in the three states of an increase in cases up to the sixteenth epidemiological week. From this point, the incidence rates in Santa Catarina progressed compared to the other states until the twenty-second epidemiological week when the trend of declining prevalence and incidence rates intensified in all three states, indicating greater effectiveness in social distancing policies.

During the analyzed period, the incidence in the state of Rio Grande do Sul showed higher rates in 2020, notably in December, and in 2022, particularly in January, whereas the state of Paraná was superior only in 2021, emphasizing the month of May.

Studies indicate that the socioeconomic context is decisive in greater vulnerability to COVID-1923,24. The population in situations of social vulnerability is most affected by the pandemic’s impacts due to the lack or insufficiency of resources, prevention strategies, and disease treatment in their daily lives, along with difficulties in practicing social distancing and maintaining employment and income. Moreover, they have reduced access to health services and basic sanitation. Hence, it is crucial to consider this scenario of social vulnerability when developing actions for health promotion, prevention, and control of COVID-1925.

Thus, the pandemic’s impact resonates across the economy, politics, and society, highlighting the need for attention to conditions that increase population vulnerability26.

The Brazilian territory is marked by inequality and inequities in access to and ownership of goods, services, and wealth, which are unevenly distributed. In the context of health, these inequalities result in significant disparities in access to technological advancements and opportunities for exposure to health determinants. Consequently, there is a rapid increase in the number of cases and mortality rates in peripheral regions of cities. In these areas, unfavorable living conditions and limited healthcare resources may contribute to a more adverse scenario in facing the pandemic and its consequences24,27.

This relationship between the pandemic and social vulnerability has also occurred in other instances, such as the Spanish flu and H1N1, demonstrating that social inequalities are determinants for the transmission and severity of these diseases28.

One of the indices that measures the degree of concentration of per capita household income distribution in a specific population and geographic area is the Gini Index, where the closer it is to one, the higher the inequality28. In 2021, Paraná presented a Gini Index of 0.475, indicating higher inequality compared to Rio Grande do Sul, which was 0.46814.

Supporting studies that relate higher COVID-19 mortality rates in regions with greater social inequalities29,30, the State of Paraná showed higher mortality rates compared to Rio Grande do Sul.

Furthermore, the results indicated a similar behavior between mortality and incidence. Rio Grande do Sul exhibited higher total annual rates in 2020 and 2022, highlighting December and February, respectively. In contrast, Paraná emphasized 2021, notably March.

The lethality of COVID-19 is influenced by intrinsic characteristics of infected individuals, such as age, pre-existing medical conditions, and lifestyle, as well as the availability of therapeutic resources like hospital beds, healthcare teams, ventilators, and medications. Therefore, when analyzing lethality, it’s crucial to consider this combination of factors that may impact the disease outcome. An integrated approach to these variables is crucial for a comprehensive understanding of COVID-19 lethality patterns and to assist in formulating effective prevention and control strategies31-33.

In Paraná, although indigenous patients represented the lowest percentage of hospitalizations compared to other groups, they exhibited the highest lethality rate in comparison with other races, with nearly half of the indigenous patients admitted resulting in death13. The low number of affected individuals might be attributed to the isolation this group maintains from urban environments, which limits virus transmission.

Lethality rates were higher in 2020 and 2021 in the state of Paraná, emphasizing April in both years. In 2022, Rio Grande do Sul had the highest lethality percentage, particularly in September. When considering the total period, the state of Paraná presented a higher lethality index compared to Rio Grande do Sul.

Furthermore, it’s worth noting that the southern region states have significant determinants capable of influencing COVID-19 mortality, incidence, and lethality rates. These states exhibit higher aging indices in Brazil34, have the highest historical incidence of severe acute respiratory syndrome, and possess a fragile public healthcare network, although more structured than in other regions of the country, such as the Northeast32.

Overall, the incidence trend was increasing in 2020 and decreasing in 2021. Mortality showed an increase in 2020 and decreased in 2021 and 2022; conversely, lethality exhibited a decreasing trend throughout the entire studied period.

In the state of Paraná, a continuous rise in COVID-19 case incidence was observed throughout the analyzed period. Regarding mortality, there was an increase in 2020 and a decrease in the years 2021 and 2022. As for lethality, compared to the initial period in 2020, there was a trend of reduction that persisted throughout the entire analysis.

In the state of Rio Grande do Sul, distinct trends were identified concerning COVID-19 pandemic indicators. The incidence of cases showed an increase in 2020 but experienced a decline in 2021. Regarding mortality, there was a rise in 2020; however, subsequent years, both in 2021 and 2022, witnessed a decrease. Finally, when analyzing lethality, it was observed that its trend throughout the entire period was decreasing.

These data indicate a favorable evolution in pandemic control within the state, with a decrease in mortality and lethality rates despite the rise in confirmed cases. It’s crucial to continue monitoring the indicators to track the epidemiological scenario and ensure the effectiveness of the prevention and control measures adopted.

Findings by Paiva et al. (2020)21 reported that urbanization changes in Rio Grande do Sul were associated with the incidence rate of COVID-19 cases. Urbanization is linked to industrialization and job generation, but this process has led to disorderly occupation of urban spaces, affecting people’s lifestyles, including difficulties in accessing healthcare services and basic hygiene conditions.

Regarding urban infrastructure and urban transit in processes related to goods acquisition and service production, increased physical contact between individuals facilitated virus spread35,36.

Additionally, the high density observed in large cities facilitated the rapid spread of the disease35 as the likelihood of contact between individuals was higher. Another ecological study confirmed the hypothesis that urbanization and the Municipal Human Development Index (IDHM) are social indicators related to the occurrence of COVID-19 cases in municipalities in Paraná21.

This situation is cause for concern as mentioned by Abreu37, the virus might encounter a population that has already suffered from the pandemic’s consequences and has limited resources in terms of education and healthcare. This could facilitate virus dissemination, contributing to the ongoing development of COVID-19 and potentially triggering new waves of the disease.

Despite the advancement of vaccination, it’s essential to adopt adequate prevention, control, and social support measures to mitigate these effects and comprehensively protect public health. Furthermore, the importance of promoting non-pharmacological measures, such as double mask use, alongside personal hygiene practices like handwashing, is emphasized37.

Therefore, it is essential to develop intervention strategies to reduce the impacts of endemic diseases, even within the context of COVID-19. However, it’s crucial that while coordinating Public Policies during a syndemic, health indicators for various infectious diseases should be monitored. This consideration involves recognizing that an intervention against one disease can negatively impact another38.

Minimizing the impacts of the COVID-19 pandemic is only possible through a scientifically evidenced-based plan for containing infectious diseases. This plan should consider the specificities and particularities of the region in question. Consequently, policymakers must remain vigilant, continuously monitor COVID-19 data, and adapt interventions while considering all stakeholders, including communities34.

The information regarding time series related to COVID-19 incidence, mortality, and lethality is still scarce in the literature, especially concerning Brazilian states, particularly in the southern region. Similar studies aim to bring robustness to the existing knowledge, enabling a deeper understanding of this scenario. Consequently, these efforts seek to provide new analytical epidemiological perspectives for the public healthcare system33,39,40.

The study was conducted through the analysis of publicly accessible population data obtained from an official source. However, it’s important to consider that this database is continually updated, implying that the results might undergo future variations due to corrections made in the records. Additionally, the data could be subject to underreporting of cases and deaths, affecting the accuracy of the information presented.

The number of accumulated COVID-19 cases could be higher than those recorded in the database as the number of specific tests for the disease was limited over the three years of the pandemic’s duration. Not all symptomatic individuals were tested. However, in this ecological study, these variations do not introduce biases in interpreting the results, allowing for a depiction of the three-year evolution of the pandemic in the states of Paraná and Rio Grande do Sul, in the Southern region of Brazil.

Therefore, time series analysis allows the dataset, with the available/possible observations for analysis, to represent one trajectory among many that could have been observed. Just as in the analysis of disease incidence (such as in the case of COVID-19) as an ecological indicator over time, this is an expression of reality because incidence on a particular day/month or year is generally correlated with the occurrence on the preceding day/month/year. This correlation is expressed in an autocorrelation function. Thus, the limitations of the study are inherent to the current analytical process for a comprehensive understanding of the pandemic’s evolution in the present scenario.

CONCLUSION

This research highlights the regional heterogeneity and disparities in incidence, mortality, and lethality, with Paraná facing more significant challenges compared to Rio Grande do Sul. These insights carry crucial implications for the development of targeted public health strategies and decision-making to effectively mitigate the impacts of COVID-19 in these specific regions.

REFERENCES

1. Organização Pan-Americana da Saúde. Coronavirus. 2023. Disponível em: https://www.paho.org/pt/topicos/coronavirus?adgroupsurvey={adgroupsurvey}&gclid=eaiaiqobchmilds169yegamvzdfuar3fewqleaayasaaegiabfd_bwe. Acesso em: 20 jul. [ Links ]

2. Organização Pan-Americana da Saúde. Histórico da pandemia de COVID-19. 2023. Disponível em: https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19. Acesso em: 20 jul. [ Links ]

3. Dos Santos Alves JC, et al. Did the COVID-19 Pandemic Disproportionately Affect the Most Socioeconomically Vulnerable Areas of Brazil?. COVID. 2023; 3(6): 924-936. Disponível em: https://www.mdpi.com/2673-8112/3/6/67. Acesso em: 5 mar. [ Links ]

4. World Health Organization. Painel coronavirus (covid-19). 2023. Disponível em: https://covid19.who.int/. Acesso em: 20 jul. [ Links ]

5. Ministério da Saúde. Ministério da saúde declara transmissão comunitária nacional. Brasil: Ministério da Saúde. 2020. Disponível em: https://www.gov.br/saude/pt-br/assuntos/noticias/ministerio-da-saude-declara-transmissao-comunitaria-nacional. Acesso em: 20 jul. [ Links ]

6. Ministério da Saúde. Portaria MS/GM n. 188, de 3 de fevereiro de 2020. Declara Emergência em Saúde Pública de importância Nacional (ESPIN) em decorrência da Infecção Humana pelo novo Coronavírus (2019-nCoV) [Internet]. Diário Oficial da União, Brasília (DF), 2020 fev 4 [citado 2020 mar 27]; Seção 1:1. [ Links ]

7. Garcia LP, Duarte E. Intervenções não farmacológicas para o enfrentamento à epidemia da COVID-19 no Brasil. Epidemiol Serv Saude. 2020; 29: e2020222. Disponível em: https://www.scielo.br/j/ress/a/B7HqzhTnWCvSXKrGd7CSjhm/. Acesso em: 5 mar. [ Links ]

8. Iser BPM, et al. Definição de caso suspeito da COVID-19: uma revisão narrativa dos sinais e sintomas mais frequentes entre os casos confirmados. Epidemiol Serv Saude. 2020; 29. Disponível em: https://www.scielo.br/j/ress/a/9ZYsW44v7MXqvkzPQm66hhD/. Acesso em: 5 mar. [ Links ]

9. Rafael RMR, et al. Effect of income on the cumulative incidence of COVID-19: an ecological study. Rev Latino-Am Enfermagem. 2020; 28. Disponível em: http://dx.doi.org/10.1590/1518-8345.4475.3344. Acesso em: 5 mar. [ Links ]

10. De Souza CDF, Machado MF, Do Carmo RF. Human development, social vulnerability and COVID-19 in Brazil: a study of the social determinants of health. Infect Dis Poverty. 2020; 9(4): 50-59. Disponível em: http://dx.doi.org/10.1186/s40249-020-00743-x. Acesso em: 5 mar. [ Links ]

11. Brasil. Ministério da Saúde. Painel Coronavírus. 2023. [Internet]. Disponível em: https://covid.saude.gov.br/. Acesso em: 09 nov. [ Links ]

12. Rio Grande do Sul. Secretaria da Saúde. Painel Coronavírus RS. 2023. Disponível em: https://ti.saude.rs.gov.br/covid19/. Acesso em: 23 jul. [ Links ]

13. Paraná. Secretaria da Saúde. Coronavírus - COVID-19. 2023. Disponível em: https://www.saude.pr.gov.br/Pagina/Coronavirus-COVID-19. Acesso em: 20 jul. 2023. [ Links ]

14. Instituto Brasileiro de Geografia e Estatística. PNAD Contínua - Pesquisa Nacional por Amostra de Domicílios Contínua. Rendimento de todas as fontes. [Internet]. 2021. Disponível em: https://www.ibge.gov.br/estatisticas/sociais/trabalho/17270-pnad-continua.html?edicao=34039Links ]

15. Gravlee CC. Systemic racism, chronic health inequities, and COVID-19: A syndemic in the making?. Am J Hum Biol. 2020; 32(5). Disponível em: http://dx.doi.org/10.1002/ajhb.23482. Acesso em: 5 mar. [ Links ]

16. Abreu LC, Elmusharaf K, Siqueira CEG. A time-series ecological study protocol to analyze trends of incidence, mortality, lethality of COVID-19 in Brazil. J Hum Growth Dev. 2021; 31(3): 491-495. 2021. Disponível em: http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-12822021000300015. Acesso em: 5 mar. [ Links ]

17. Zeger SL, Irizarry R, Peng RD. On time series analysis of public health and biomedical data. Annu. Rev. Public Health. 2006; 27: 57-79. Disponível em: http://dx.doi.org/10.1146/annurev.publhealth.26.021304.144517. Acesso em: 5 mar. [ Links ]

18. Antunes JL, Cardoso MR. Uso da análise de séries temporais em estudos epidemiológicos. Epidemiol Serv Saude. 2015; 24: 565-576. Disponível em: https://www.scielo.br/j/ress/a/zzG7bfRbP7xSmqgWX7FfGZL/abstract/?lang=pt. Acesso em: 5 mar. [ Links ]

19. Governo do Estado do Paraná. Transparência - enfrentamento ao coronavírus - legislação [Internet]. Coronavírus. [citado 30 de maio de 2023]. Disponível em: https://www.coronavirus.pr.gov.br/Campanha/Pagina/TRANSPARENCIA-Enfrentamento-ao-Coronavirus-Legislacao. [ Links ]

20. Secretaria de Saúde. Decretos estaduais. Coronavírus. 2020 [citado 30 de maio de 2023]. Disponível em: https://coronavirus.rs.gov.br/decretos-estaduais. Acessado em: 23 jul 2023. [ Links ]

21. Paiva CI, et al. Perfil epidemiológico da Covid-19 no Estado do Paraná. Rev Saude Publica Paraná. 2020; 3(Supl.). Disponível em: http://revista.escoladesaude.pr.gov.br/index.php/rspp/article/view/419. Acesso em: 5 mar. [ Links ]

22. Klokner SGM, et al. Perfil epidemiológico e preditores de fatores de risco para a COVID-19 na região sul do Brasil. Res Soc Dev. 2021; 10(3): e17710313197-e17710313197. Disponível em: https://www.researchgate.net/publication/350023230_Perfil_epidemiologico_e_preditores_de_fatores_de_risco_para_a_COVID-19_na_regiao_sul_do_Brasil. Acesso em: 5 mar. [ Links ]

23. Rezende LFM, et al. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil. Rev Saude Publica. 2020; 54: 50. Disponível em: http://dx.doi.org/10.11606/s1518-8787.2020054002596. Acesso em: 5 mar. [ Links ]

24. Da Silva MHA, Procópio IM. A fragilidade do sistema de saúde brasileiro e a vulnerabilidade social diante da COVID-19. Rev Bras Promoç Saúde. 2020; 33. Disponível em: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1099893. Acesso em: 5 mar. [ Links ]

25. Pires RRC. Os efeitos sobre grupos sociais e territórios vulnerabilizados das medidas de enfrentamento à crise sanitária da COVID-19: propostas para o aperfeiçoamento da ação pública. 2020. Disponível em: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-617913. Acesso em: 5 mar. [ Links ]

26. Freitas CM, Silva IV, Cidade NC. COVID-19 as a global disaster: challenges to risk governance and social vulnerability in Brazil. Ambiente Soc. 2020; 23: e0115. Disponível em: https://www.scielo.br/j/asoc/a/CF85xcF8ywdgHgbPRGdfKTb/. Acesso em: 5 mar. [ Links ]

27. Cestari VRF, et al. Vulnerabilidade social e incidência de COVID-19 em uma metrópole brasileira. Cienc Saude Colet. 2021; 26: 1023-1033. Disponível em: https://www.scielo.br/j/csc/a/dh9JmJfQLXKG3tcHHndQ55H/. Acesso em; 5 mar. [ Links ]

28. Calmon TVL. As condições objetivas para o enfrentamento ao COVID-19: abismo social brasileiro, o racismo, e as perspectivas de desenvolvimento social como determinantes. NAU Social. 2020; 11(20): 131-136. Disponível em: https://periodicos.ufba.br/index.php/nausocial/article/view/36543. Acesso em: 5 mar. [ Links ]

29. Fortunato RA, Lima C, Priori L. COVID-19 no Brasil: a evolução da doença num cenário de desigualdades sociais. Middle Atl Rev Lat Am Stud. 2020; 4(1): 26-30. Disponível em: https://marlasjournal.com/articles/10.23870/marlas.310. Acesso em: 5 mar. [ Links ]

30. Feng Y, et al. COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med. 2020; 201(11): 1380-1388. Disponível em: http://dx.doi.org/10.1164/rccm.202002-0445OC. Acesso em: 5 mar. [ Links ]

31. Miranda GMD, Mendes ACG, Silva ALA. Population aging in Brazil: current and future social challenges and consequences. Rev Bras Geriatr Gerontol. 2016; 19: 507-519. Disponível em: https://www.scielo.br/j/rbgg/a/MT7nmJPPRt9W8vndq8dpzDP/. Acesso em: 5 mar. [ Links ]

32. Bastos LS, Niquini RP, Lana RM, Villela DAM, Cruz OG, Coelho FC, et al. COVID-19 and hospitalizations for SARI in Brazil: a comparison up to the 12th epidemiological week of 2020. Cad Saude Publica. 2020; 36. Disponível em: http://dx.doi.org/10.1590/0102-311X00070120. Acesso em: 5 mar. [ Links ]

33. Silva CG, Daboin BEG, Monteiro CBM. Analysis of incidence, mortality, and lethality by COVID-19 in the States of Pará and Rio Grande do Sul, Brazil: epidemiological aspects of evolution 2020-2022. J Hum Growth Dev. 2023; 33(3): 431-443. DOI: 10.36311/jhgd.v33.15287. Disponível em: https://revistas.marilia.unesp.br/index.php/jhgd/article/view/15287. Acesso em: 5 mar. [ Links ]

34. Calabrò GE, et al. The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence. Vaccines. 2023; 11(5): 1011. Disponível em: http://dx.doi.org/10.3390/vaccines11051011. Acesso em: 5 mar. [ Links ]

35. Maciel JAC, Castro-Silva II, Farias MR. Análise inicial da correlação espacial entre a incidência de COVID-19 e o desenvolvimento humano nos municípios do estado do Ceará no Brasil. Rev Bras Epidemiol. 2020; 23. Disponível em: http://dx.doi.org/10.1590/1980-549720200057. Acesso em: 5 mar. [ Links ]

36. Da Silva Martinuci O, et al. Dispersão da covid-19 no estado do Paraná. Hygeia: Rev Bras Geogr Med Saude. 2020; (Especial): 251. Disponível em: https://seer.ufu.br/index.php/hygeia/article/view/54619. Acesso em: 5 mar. [ Links ]

37. Abreu LC. The path of humanity in the pandemic of COVID-19: the choice of the realistic, optimist or pessimist scenario. J Hum Growth Dev. 2021; 31(1): 5-8. Disponível em: http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-12822021000100001. Acesso em: 5 mar. [ Links ]

38. Cavany SM, et al. Optimizing the deployment of ultra-low volume and targeted indoor residual spraying for dengue outbreak response. PLoS Comput Biol. 2020; 16(4): e1007743. Disponível em: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1007743&type=printable. Acesso em: 5 mar. [ Links ]

39. Brito SA, Abreu LC, Estrada DA, Campos MF, Cavalcanti MPE, Carvalho AAS. Three years of COVID-19 pandemic: comparative analysis of incidence, lethality and mortality among the States of the south region of Brazil. J Hum Growth Dev. 2023; 33 (3): 392-404. Disponível em: https://revistas.marilia.unesp.br/index.php/jhgd/article/view/15285. Acesso em: 5 mar. [ Links ]

40. Silva FF, et al. Temporal Analysis of COVID-19 Epidemiological Indicators in a Low-Income Brazilian Context: A Retrospective Analysis in Paraiba State. Viruses. 2023; 15(10): 2016. Disponível em: http://dx.doi.org/10.3390/v15102016. Acesso em: 5 mar. coronavirus?adgroupsurvey={adgroupsurvey}&gclid=eaiaiqobchmilds169yegamvzdfuar3fewqleaayasaaegiabfd_bwe. Acesso em: 20 jul. [ Links ]

Received: May 2023; Accepted: December 2023; Published: April 2024

Corresponding author: daniel.alvarez.estrada@gmail.com

Creative Commons License this article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.